semaglutide osteoporosis New studies have raised fresh alarms about the popular “weight-loss drug” Ozempic, revealing it may accelerate bone loss and weaken skeletal health in users. Research published in 2025–2026 shows patients on Weight loss induced bone loss:
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 28.Team R, RStudio

doi: 10.1136/bmj.n160

But theyre licensed for different uses in the UK: Ozempic for Type 2 Diabetes, and Wegovy for weight loss in people with a BMI 27 (with conditions) or 30
.jpg)
Write it down, check it twice

3 / 7 CareClinic CareClinic is the app people turn to when GLP-1 side effects feel unpredictable
